A novel desmoplakin mutation causes dilated cardiomyopathy with palmoplantar keratoderma as an early clinical sign

• Published in: Journal of the European Academy of Dermatology and Venereology Vol. 36; no. 8; pp. 1349 - 1358
• Main Authors: Karvonen, V., Harjama, L., Heliö, K., Kettunen, K., Elomaa, O., Koskenvuo, J.W., Kere, J., Weckström, S., Holmström, M., Saarela, J., Ranki, A., Heliö, T., Hannula‐Jouppi, K.
• Format: Journal Article
• Language: English
• Published: England 01-08-2022
• Subjects: dilated cardiomyopathy; genodermatosis; Medicin och hälsovetenskap; next‐generation sequencing; palmoplantar keratoderma; genodermatosis; next-generation sequencing; palmoplantar keratoderma; dilated cardiomyopathy
• ISSN: 0926-9959; 1468-3083; 1468-3083
• DOI: 10.1111/jdv.18164

Background
PPKs represent a heterogeneous group of disorders with hyperkeratosis of palmar and/or plantar skin. PPK, hair shaft abnormalities, cardiomyopathy and arrhythmias can be caused by mutations in desmosomal genes, e.g. desmoplakin (DSP). PPK should trigger genetic testing to reveal mutations with possible related cardiac disease.
Objectives
To report a large multigenerational family with a novel DSP mutation associated with early‐onset PPK and adult‐onset cardiomyopathy and arrhythmias.
Methods
A custom‐designed in‐house panel of 35 PPK related genes was used to screen mutations in the index patient with focal PPK. The identified DSP mutation was verified by Sanger sequencing. DNA samples from 20 members of the large multigenerational family were sequenced for the DSP mutation. Medical records were reviewed. Clinical dermatological evaluation was performed, including light microscopy of hair samples. Cardiac evaluation included clinical examination, echocardiography, cardiac magnetic resonance imaging (CMR), electrocardiogram (ECG), Holter monitoring and laboratory tests.
Results
We identified a novel autosomal dominant truncating DSP c.2493delA p.(Glu831Aspfs*33) mutation associated with dilated cardiomyopathy (DCM) with arrhythmia susceptibility and focal PPK as an early cutaneous sign. The mutation was found in nine affected family members, but not in any unaffected members. Onset of dermatological findings preceded cardiac symptoms which were variable and occurred at adult age.
Conclusions
We report a novel truncating DSP mutation causing focal PPK with varying severity and left ventricular dilatation and ventricular extrasystoles. This finding emphasizes the importance of genetic diagnosis in patients with PPK for clinical counselling and management of cardiomyopathies and arrhythmias.